ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279

ITP and the Center of QuantumBioSciences is part of newly approved Collaborative Research Center 1279 on “Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents”. Our team contributes to the CRC with a project on hyperpolarized nanodiamond as contrast agents for cancer research. Funded initially for a period of 4 years the CRC may be extended for a duration of up to 12 years.

<link med fakultaet med-detailseiten news-detail article rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv>www.uni-ulm.de/med/fakultaet/med-detailseiten/news-detail/article/rund-121-millionen-neuer-peptid-sonderforschungsbereich-koerpereigene-wirkstoffe-gegen-hiv/

Contact X logoGitHub logo

Ulm University
Institute of Theoretical Physics
Albert-Einstein-Allee 11
D - 89081 Ulm
Germany

Tel: +49 731 50 22911
Fax: +49 731 50 22924

Office: Building M26, room 4117

Click here if you are interested in joining the group.

Most Recent Papers

13C hyperpolarization with nitrogen-vacancy centers in micro- and nanodiamonds for sensitive magnetic resonance applications, Sci. Adv. 11, eadq6836 (2025), arXiv:2403.14521

YASTN: Yet another symmetric tensor networks; A Python library for Abelian symmetric tensor network calculations, SciPost Phys. Codebases (2025), arXiv:2405.12196

Unlocking Heisenberg Sensitivity with Sequential Weak Measurement Preparation, Quantum 9, 1590 (2025), arXiv:2403.05954

Time dependent Markovian master equation beyond the adiabatic limit, Quantum 8, 1534 (2024), arXiv:2304.06166

Spectral density modulation and universal Markovian closure of fermionic environments, J. Chem. Phys. 161, 174114 (2024), arXiv:2407.10017